LOGO
LOGO

Myomo Reports 154% Revenue Growth For Q4, Provides 2025 Guidance

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Myomo, Inc. (MYO), a wearable medical robotics company, on Monday, reported financial results for the three months and year ended December 31, 2024.

The company recorded a revenue of $12.1 million for the fourth quarter of 2024, a 154 percent increase compared to the revenue of $4.7 million in the same period in 2023.

Revenue was recognized from 220 MyoPro units in the fourth quarter of 2024, up 106 percent from the year-ago period. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.